View more on these topics

Sitka sets out health plan

Sitka is aiming to boost the Sitka Health Fund VCT by raising a further £10m through a C1 share offer.

The VCT, which invests in unquoted companies in the healthcare sector, has raised £10m since it was established in 2001. The healthcare sector includes companies at various stages of development in areas such as the development of new drugs and the supply of specialist software to the pharmaceutical industry.

The directors of the VCT regard the health industry in the UK as second only to the US in terms of venture capital financing and the development of pharmaceutical and bioscience companies. They believe now is an appropriate time to raise more money due the relatively stable economic outlook and the introduction of the enhanced income tax reliefs for VCTs, which will last until April 2006.

One advantage a top-up issue has over a new VCT is that investors can gain access to an existing portfolio of 12 companies. Companies with an experienced management team, a good business plan, products based on patented intellectual property, revenue and growth potential and the potential to make profits within two to four years stand a good chance of making it into the portfolio.

As a specialist product, this may be useful for VCT investors who see that there is an increasing demand for healthcare products and services with technical and medical advances throwing up opportunities to market innovative products.

Generalist VCTs are less likely to invest in this sector because a great deal of industry knowledge is needed to assess companies and generalist managers may not have this.

However, in addition to the usual risks of investing in unquoted companies, there are some sector-specific risks. Some health products need to go through clinical trials and this may be a long process and could result in the product being found unsuitable for marketing to the general public.


Fine line for bond firms

The with-profits bond has taken its fair share of criticism but negative publicity for the product stepped up a notch recently after Bradford & Bingley was hit with a fine for widespread misselling both of with-profits and precipice bonds.

Charity Bank offers tax breaks

Charity Bank – a not-for-profit bank – is offering a five year tax efficient savings account that offers savers 5 per cent per a year tax relief plus 2 per cent annual interest on all deposits. Charity Bank says the 5 per cent a year tax relief is equivalent to a gross return of 8.33 […]

Thoresen set for ScotEq decision

Aegon UK chief executive Otto Thoresen faces some challenging decisions in his first months in charge with the firm set to determine the future of the Scottish Equitable brand and its role in the stakeholder market.

Jupiter recruits to develop fund teams

Jupiter Unit Trust Managers has take on a new fund manager and a business develoment director.
The asset manager has taken on fomer Cazenove fund manager Simon Somerville to lead its assault on Asian markets.
Meanwhile, former chief executive of Invesco Europe Tristan Hillgarth has been appointed to the newly created position of group business development director.
Jupiter celebrated its 20th birthday this week.


News and expert analysis straight to your inbox

Sign up


    Leave a comment


    Why register with Money Marketing ?

    Providing trusted insight for professional advisers.  Since 1985 Money Marketing has helped promote and analyse the financial adviser community in the UK and continues to be the trusted industry brand for independent insight and advice.

    News & analysis delivered directly to your inbox
    Register today to receive our range of news alerts including daily and weekly briefings

    Money Marketing Events
    Be the first to hear about our industry leading conferences, awards, roundtables and more.

    Research and insight
    Take part in and see the results of Money Marketing's flagship investigations into industry trends.

    Have your say
    Only registered users can post comments. As the voice of the adviser community, our content generates robust debate. Sign up today and make your voice heard.

    Register now

    Having problems?

    Contact us on +44 (0)20 7292 3712

    Lines are open Monday to Friday 9:00am -5.00pm